Brain STAT5 signaling modulates learning and memory formation

Autor(es):Mostrar menos -

Furigo, Isadora C. ^[1] ; Melo, Helen M. ^[2] ; Lyra e Silva, Natalia M. ^[2] ; Ramos-Lobo, Angela M. ^[1] ; Teixeira, Pryscila D. S. ^[1] ; Buonfiglio, Daniella C. ^[1] ; Wasinski, Frederick ^[1] ; Lima, Eliana R. ^[3] ; Higuti, Eliza ^[3] ; Peroni, Cibele N. ^[3] ; Bartolini, Paolo ^[3] ; Soares, Carlos R. J. ^[3] ; Metzger, Martin ^[1] ; de Felice, Fernanda G. ^{[2, 4]} ; Donato, Jr., Jose ^[1]

Afiliação do(s) autor(es)

^[1] Univ Sao Paulo, Inst Biomed Sci, Dept Physiol & Biophys, Ave Prof Lineu Prestes 1524, BR-05508000 Sao Paulo, SP - Brazil

^[2] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo Meis, BR-21944590 Rio De Janeiro, RJ - Brazil

^[3] IPEN CNEN, Ctr Biotechnol, BR-05508900 Sao Paulo, SP - Brazil

^[4] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON K7L 3N6 - Canada

• Tipo de documento: Artigo Científico
• Fonte: Brain Structure & Function; v. 223, n. 5, p. 2229-2241, JUN 2018.
• Citações Web of Science: 9

Resumo

The signal transducer and activator of transcription 5 (STAT5) is a transcription factor recruited by numerous cytokines. STAT5 is important for several physiological functions, including body and tissue growth, mammary gland development, immune system and lipid metabolism. However, the role of STAT5 signaling for brain functions is still poorly investigated, especially regarding cognitive aspects. Therefore, the objective of the present study was to investigate whether brain STAT5 signaling modulates learning and memory formation. For this purpose, brain-specific STAT5 knockout (STAT5 KO) mice were studied in well-established memory tests. Initially, we confirmed a robust reduction in STAT5a and STAT5b mRNA levels in different brain structures of STAT5 KO mice. STAT5 KO mice showed no significant alterations in metabolism, growth, somatotropic axis and spontaneous locomotor activity. In contrast, brain-specific STAT5 ablation impaired learning and memory formation in the novel object recognition, Barnes maze and contextual fear conditioning tests. To unravel possible mechanisms that might underlie the memory deficits of STAT5 KO mice, we assessed neurogenesis in the hippocampus, but no significant differences were observed between groups. On the other hand, reduced insulin-like growth factor-1 (IGF-1) mRNA expression was found in the hippocampus and hypothalamus of STAT5 KO mice. These findings collectively indicate that brain STAT5 signaling is required to attain normal learning and memory. Therefore, STAT5 is an important downstream cellular mechanism shared by several cytokines to regulate cognitive functions. (AU)

• Processo FAPESP: 16/20897-3 - Papel dos neurônios orexina como mediadores dos efeitos centrais induzidos pelo hormônio do crescimento
• Beneficiário: Frederick Wasinski
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 14/11752-6 - Estudo das funções da leptina durante o período intrauterino e infância no camundongo
• Beneficiário: Angela Maria Ramos Lobo
• Modalidade de apoio: Bolsas no Brasil - Doutorado
• Processo FAPESP: 12/02388-3 - Topografia e assinatura neuroquímica das projeções entre a habenula lateral, o núcleo rostromedial tegmental e o núcleo dorsal da rafe no rato
• Beneficiário: Martin Andreas Metzger
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 16/09679-4 - Estudo dos efeitos centrais do hormônio do crescimento sobre o metabolismo energético e controle glicêmico
• Beneficiário: Isadora Clivatti Furigo
• Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
• Processo FAPESP: 15/10992-6 - Estudo da programação metabólica por meio de diferentes abordagens
• Beneficiário: Jose Donato Junior
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 17/02983-2 - Ação do hormônio do crescimento no sistema nervoso: relevância para as funções neurais e na doença
• Beneficiário: Jose Donato Junior
• Modalidade de apoio: Auxílio à Pesquisa - Temático
• Processo FAPESP: 12/24345-4 - Avaliação do potencial de antagonistas de prolactina para o tratamento da obesidade e do Diabetes mellitus 2
• Beneficiário: Carlos Roberto Jorge Soares
• Modalidade de apoio: Auxílio à Pesquisa - Regular